GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Machinery, Furniture, Equipment

Incanthera (AQSE:INC) Machinery, Furniture, Equipment : £0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Machinery, Furniture, Equipment?

Incanthera's Machinery, Furniture, Equipment for the quarter that ended in Sep. 2023 was £0.00 Mil.

Incanthera's quarterly Machinery, Furniture, Equipment increased from Sep. 2022 (£0.00 Mil) to Mar. 2023 (£0.05 Mil) but then declined from Mar. 2023 (£0.05 Mil) to Sep. 2023 (£0.00 Mil).

Incanthera's annual Machinery, Furniture, Equipment increased from Mar. 2021 (£0.05 Mil) to Mar. 2022 (£0.05 Mil) but then stayed the same from Mar. 2022 (£0.05 Mil) to Mar. 2023 (£0.05 Mil).


Incanthera Machinery, Furniture, Equipment Historical Data

The historical data trend for Incanthera's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Machinery, Furniture, Equipment Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Machinery, Furniture, Equipment
- 0.05 0.05 0.05

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Machinery, Furniture, Equipment Get a 7-Day Free Trial - 0.05 - 0.05 -

Incanthera Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Incanthera (AQSE:INC) Business Description

Industry
Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines